nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketamine—ABCB1—hematologic cancer	0.0728	1	CbGaD
Ketamine—CYP2B6—Thiotepa—hematologic cancer	0.0287	0.0485	CbGbCtD
Ketamine—PTGS1—Bortezomib—hematologic cancer	0.0279	0.047	CbGbCtD
Ketamine—PTGS1—Thalidomide—hematologic cancer	0.0243	0.041	CbGbCtD
Ketamine—PTGS1—Ifosfamide—hematologic cancer	0.0214	0.0361	CbGbCtD
Ketamine—PTGS1—Imatinib—hematologic cancer	0.0204	0.0345	CbGbCtD
Ketamine—CYP2C9—Bexarotene—hematologic cancer	0.0183	0.0309	CbGbCtD
Ketamine—ABCB1—Lenalidomide—hematologic cancer	0.0177	0.03	CbGbCtD
Ketamine—CYP2B6—Ifosfamide—hematologic cancer	0.0163	0.0275	CbGbCtD
Ketamine—CYP2C8—Bortezomib—hematologic cancer	0.0161	0.0271	CbGbCtD
Ketamine—CYP2C9—Idarubicin—hematologic cancer	0.0152	0.0256	CbGbCtD
Ketamine—CYP2B6—Nilotinib—hematologic cancer	0.0141	0.0239	CbGbCtD
Ketamine—CYP2C8—Ifosfamide—hematologic cancer	0.0123	0.0208	CbGbCtD
Ketamine—CYP2C9—Bortezomib—hematologic cancer	0.0112	0.0189	CbGbCtD
Ketamine—CYP2C8—Nilotinib—hematologic cancer	0.0107	0.0181	CbGbCtD
Ketamine—CYP3A4—Bexarotene—hematologic cancer	0.0106	0.018	CbGbCtD
Ketamine—ABCB1—Daunorubicin—hematologic cancer	0.0104	0.0176	CbGbCtD
Ketamine—PTGS1—Etoposide—hematologic cancer	0.0102	0.0172	CbGbCtD
Ketamine—ABCB1—Alitretinoin—hematologic cancer	0.0102	0.0172	CbGbCtD
Ketamine—CYP3A4—Busulfan—hematologic cancer	0.00989	0.0167	CbGbCtD
Ketamine—CYP3A4—Lomustine—hematologic cancer	0.00989	0.0167	CbGbCtD
Ketamine—CYP2C9—Thalidomide—hematologic cancer	0.00977	0.0165	CbGbCtD
Ketamine—CYP2B6—Irinotecan—hematologic cancer	0.00971	0.0164	CbGbCtD
Ketamine—CYP2C9—Teniposide—hematologic cancer	0.00932	0.0157	CbGbCtD
Ketamine—CYP3A4—Thiotepa—hematologic cancer	0.00881	0.0149	CbGbCtD
Ketamine—CYP2C9—Ifosfamide—hematologic cancer	0.0086	0.0145	CbGbCtD
Ketamine—CYP2C9—Imatinib—hematologic cancer	0.00821	0.0139	CbGbCtD
Ketamine—ABCB1—Imatinib—hematologic cancer	0.00797	0.0135	CbGbCtD
Ketamine—CYP2B6—Cisplatin—hematologic cancer	0.00792	0.0134	CbGbCtD
Ketamine—CYP2C9—Nilotinib—hematologic cancer	0.00746	0.0126	CbGbCtD
Ketamine—ABCB1—Nilotinib—hematologic cancer	0.00724	0.0122	CbGbCtD
Ketamine—ABCB1—Vinorelbine—hematologic cancer	0.00718	0.0121	CbGbCtD
Ketamine—CYP3A4—Methoxsalen—hematologic cancer	0.00685	0.0116	CbGbCtD
Ketamine—CYP3A4—Bortezomib—hematologic cancer	0.00652	0.011	CbGbCtD
Ketamine—ABCB1—Dasatinib—hematologic cancer	0.0064	0.0108	CbGbCtD
Ketamine—CYP2B6—Dexamethasone—hematologic cancer	0.00639	0.0108	CbGbCtD
Ketamine—ABCB1—Mitoxantrone—hematologic cancer	0.00632	0.0107	CbGbCtD
Ketamine—CYP3A4—Daunorubicin—hematologic cancer	0.00623	0.0105	CbGbCtD
Ketamine—CYP2C8—Etoposide—hematologic cancer	0.00589	0.00995	CbGbCtD
Ketamine—ABCB1—Betamethasone—hematologic cancer	0.00564	0.00952	CbGbCtD
Ketamine—ABCB1—Gemcitabine—hematologic cancer	0.00559	0.00943	CbGbCtD
Ketamine—ABCB1—Prednisolone—hematologic cancer	0.00556	0.00939	CbGbCtD
Ketamine—CYP3A4—Cytarabine—hematologic cancer	0.0055	0.00929	CbGbCtD
Ketamine—CYP3A4—Teniposide—hematologic cancer	0.00542	0.00915	CbGbCtD
Ketamine—CYP2B6—Doxorubicin—hematologic cancer	0.00531	0.00896	CbGbCtD
Ketamine—ABCB1—Prednisone—hematologic cancer	0.00525	0.00887	CbGbCtD
Ketamine—CYP3A4—Ifosfamide—hematologic cancer	0.005	0.00844	CbGbCtD
Ketamine—ABCB1—Irinotecan—hematologic cancer	0.00498	0.00841	CbGbCtD
Ketamine—CYP2C8—Dexamethasone—hematologic cancer	0.00484	0.00818	CbGbCtD
Ketamine—CYP3A4—Imatinib—hematologic cancer	0.00478	0.00807	CbGbCtD
Ketamine—CYP3A4—Ruxolitinib—hematologic cancer	0.0045	0.0076	CbGbCtD
Ketamine—ABCB1—Vinblastine—hematologic cancer	0.00443	0.00748	CbGbCtD
Ketamine—ABCB1—Vincristine—hematologic cancer	0.00435	0.00735	CbGbCtD
Ketamine—CYP3A4—Nilotinib—hematologic cancer	0.00434	0.00733	CbGbCtD
Ketamine—CYP3A4—Vinorelbine—hematologic cancer	0.0043	0.00727	CbGbCtD
Ketamine—CYP2C9—Cisplatin—hematologic cancer	0.00418	0.00706	CbGbCtD
Ketamine—ABCB1—Cisplatin—hematologic cancer	0.00406	0.00685	CbGbCtD
Ketamine—ABCB1—Etoposide—hematologic cancer	0.00399	0.00674	CbGbCtD
Ketamine—CYP3A4—Triamcinolone—hematologic cancer	0.00394	0.00665	CbGbCtD
Ketamine—GRIN3B—lung—hematologic cancer	0.00385	0.102	CbGeAlD
Ketamine—CYP3A4—Dasatinib—hematologic cancer	0.00384	0.00648	CbGbCtD
Ketamine—CYP3A4—Mitoxantrone—hematologic cancer	0.00379	0.0064	CbGbCtD
Ketamine—GRIN3B—testis—hematologic cancer	0.00364	0.0962	CbGeAlD
Ketamine—CYP2C9—Dexamethasone—hematologic cancer	0.00338	0.00571	CbGbCtD
Ketamine—CYP3A4—Betamethasone—hematologic cancer	0.00338	0.0057	CbGbCtD
Ketamine—CYP3A4—Prednisolone—hematologic cancer	0.00333	0.00563	CbGbCtD
Ketamine—ABCB1—Dexamethasone—hematologic cancer	0.00328	0.00554	CbGbCtD
Ketamine—CYP3A4—Prednisone—hematologic cancer	0.00315	0.00531	CbGbCtD
Ketamine—CYP3A4—Irinotecan—hematologic cancer	0.00298	0.00504	CbGbCtD
Ketamine—ABCB1—Doxorubicin—hematologic cancer	0.00272	0.00459	CbGbCtD
Ketamine—CYP3A4—Vinblastine—hematologic cancer	0.00265	0.00448	CbGbCtD
Ketamine—ABCB1—Methotrexate—hematologic cancer	0.00263	0.00445	CbGbCtD
Ketamine—CYP3A4—Vincristine—hematologic cancer	0.00261	0.0044	CbGbCtD
Ketamine—TACR1—hematopoietic system—hematologic cancer	0.00242	0.0639	CbGeAlD
Ketamine—CYP3A4—Etoposide—hematologic cancer	0.00239	0.00404	CbGbCtD
Ketamine—CYP3A4—Dexamethasone—hematologic cancer	0.00196	0.00332	CbGbCtD
Ketamine—GRIN2C—testis—hematologic cancer	0.00175	0.0462	CbGeAlD
Ketamine—CYP3A4—Doxorubicin—hematologic cancer	0.00163	0.00275	CbGbCtD
Ketamine—GRIN2D—testis—hematologic cancer	0.00162	0.043	CbGeAlD
Ketamine—TACR1—blood—hematologic cancer	0.0016	0.0423	CbGeAlD
Ketamine—GRIN3A—testis—hematologic cancer	0.00153	0.0404	CbGeAlD
Ketamine—TACR1—lung—hematologic cancer	0.0014	0.0371	CbGeAlD
Ketamine—OPRM1—hematopoietic system—hematologic cancer	0.00134	0.0354	CbGeAlD
Ketamine—TACR1—testis—hematologic cancer	0.00132	0.035	CbGeAlD
Ketamine—GRIN2A—testis—hematologic cancer	0.00121	0.0319	CbGeAlD
Ketamine—TACR1—lymph node—hematologic cancer	0.00096	0.0254	CbGeAlD
Ketamine—OPRM1—blood—hematologic cancer	0.000887	0.0235	CbGeAlD
Ketamine—CYP2C8—hematopoietic system—hematologic cancer	0.000805	0.0213	CbGeAlD
Ketamine—SLC6A2—gonad—hematologic cancer	0.000745	0.0197	CbGeAlD
Ketamine—OPRM1—testis—hematologic cancer	0.000734	0.0194	CbGeAlD
Ketamine—CYP2B6—hematopoietic system—hematologic cancer	0.000722	0.0191	CbGeAlD
Ketamine—CYP2C9—hematopoietic system—hematologic cancer	0.000715	0.0189	CbGeAlD
Ketamine—PTGS1—hematopoietic system—hematologic cancer	0.000653	0.0173	CbGeAlD
Ketamine—SLC6A2—lung—hematologic cancer	0.000569	0.0151	CbGeAlD
Ketamine—CYP2B6—gonad—hematologic cancer	0.000549	0.0145	CbGeAlD
Ketamine—CYP3A4—hematopoietic system—hematologic cancer	0.000545	0.0144	CbGeAlD
Ketamine—SLC6A2—testis—hematologic cancer	0.000537	0.0142	CbGeAlD
Ketamine—CYP2C8—blood—hematologic cancer	0.000533	0.0141	CbGeAlD
Ketamine—DRD2—lung—hematologic cancer	0.000519	0.0137	CbGeAlD
Ketamine—DRD2—testis—hematologic cancer	0.000489	0.0129	CbGeAlD
Ketamine—CYP2B6—blood—hematologic cancer	0.000479	0.0127	CbGeAlD
Ketamine—CYP2C9—blood—hematologic cancer	0.000474	0.0125	CbGeAlD
Ketamine—CYP2C8—testis—hematologic cancer	0.000441	0.0117	CbGeAlD
Ketamine—PTGS1—blood—hematologic cancer	0.000433	0.0114	CbGeAlD
Ketamine—CYP2B6—lung—hematologic cancer	0.000419	0.0111	CbGeAlD
Ketamine—CYP2B6—testis—hematologic cancer	0.000396	0.0105	CbGeAlD
Ketamine—SLC6A2—lymph node—hematologic cancer	0.000389	0.0103	CbGeAlD
Ketamine—ABCB1—hematopoietic system—hematologic cancer	0.000386	0.0102	CbGeAlD
Ketamine—PTGS1—lung—hematologic cancer	0.000379	0.01	CbGeAlD
Ketamine—CYP3A4—blood—hematologic cancer	0.000361	0.00956	CbGeAlD
Ketamine—PTGS1—testis—hematologic cancer	0.000358	0.00947	CbGeAlD
Ketamine—ABCB1—gonad—hematologic cancer	0.000294	0.00776	CbGeAlD
Ketamine—PTGS1—lymph node—hematologic cancer	0.000259	0.00686	CbGeAlD
Ketamine—ABCB1—blood—hematologic cancer	0.000256	0.00677	CbGeAlD
Ketamine—ABCB1—bone marrow—hematologic cancer	0.000247	0.00655	CbGeAlD
Ketamine—ABCB1—lung—hematologic cancer	0.000224	0.00593	CbGeAlD
Ketamine—ABCB1—testis—hematologic cancer	0.000212	0.0056	CbGeAlD
Ketamine—Pain—Bleomycin—hematologic cancer	0.00019	0.00121	CcSEcCtD
Ketamine—Anaphylactic shock—Ifosfamide—hematologic cancer	0.000189	0.00121	CcSEcCtD
Ketamine—Nausea—Busulfan—hematologic cancer	0.000189	0.00121	CcSEcCtD
Ketamine—Vision blurred—Cisplatin—hematologic cancer	0.000189	0.0012	CcSEcCtD
Ketamine—Shock—Alitretinoin—hematologic cancer	0.000189	0.0012	CcSEcCtD
Ketamine—Hypotension—Thalidomide—hematologic cancer	0.000188	0.0012	CcSEcCtD
Ketamine—Pain—Vinorelbine—hematologic cancer	0.000187	0.00119	CcSEcCtD
Ketamine—Arrhythmia—Prednisolone—hematologic cancer	0.000186	0.00119	CcSEcCtD
Ketamine—Anaphylactic shock—Vincristine—hematologic cancer	0.000185	0.00118	CcSEcCtD
Ketamine—Anorexia—Carmustine—hematologic cancer	0.000184	0.00118	CcSEcCtD
Ketamine—Nausea—Procarbazine—hematologic cancer	0.000184	0.00117	CcSEcCtD
Ketamine—Anorexia—Alitretinoin—hematologic cancer	0.000183	0.00117	CcSEcCtD
Ketamine—Vomiting—Chlorambucil—hematologic cancer	0.000182	0.00116	CcSEcCtD
Ketamine—Decreased appetite—Thiotepa—hematologic cancer	0.000181	0.00116	CcSEcCtD
Ketamine—Erythema—Prednisolone—hematologic cancer	0.000181	0.00115	CcSEcCtD
Ketamine—Hypotension—Carmustine—hematologic cancer	0.000181	0.00115	CcSEcCtD
Ketamine—Anorexia—Ifosfamide—hematologic cancer	0.000181	0.00115	CcSEcCtD
Ketamine—Nausea—Dasatinib—hematologic cancer	0.00018	0.00115	CcSEcCtD
Ketamine—Nausea—Bexarotene—hematologic cancer	0.00018	0.00115	CcSEcCtD
Ketamine—Anaphylactic shock—Irinotecan—hematologic cancer	0.00018	0.00115	CcSEcCtD
Ketamine—Anaphylactic shock—Mitoxantrone—hematologic cancer	0.00018	0.00115	CcSEcCtD
Ketamine—Nausea—Fludarabine—hematologic cancer	0.00018	0.00115	CcSEcCtD
Ketamine—Hypotension—Alitretinoin—hematologic cancer	0.000179	0.00114	CcSEcCtD
Ketamine—Pain—Thiotepa—hematologic cancer	0.000178	0.00114	CcSEcCtD
Ketamine—Vomiting—Nilotinib—hematologic cancer	0.000178	0.00114	CcSEcCtD
Ketamine—Vomiting—Imatinib—hematologic cancer	0.000177	0.00113	CcSEcCtD
Ketamine—Hypotension—Ifosfamide—hematologic cancer	0.000177	0.00113	CcSEcCtD
Ketamine—Shock—Mitoxantrone—hematologic cancer	0.000177	0.00113	CcSEcCtD
Ketamine—Shock—Irinotecan—hematologic cancer	0.000177	0.00113	CcSEcCtD
Ketamine—Rash—Nilotinib—hematologic cancer	0.000177	0.00113	CcSEcCtD
Ketamine—Bradycardia—Betamethasone—hematologic cancer	0.000176	0.00113	CcSEcCtD
Ketamine—Bradycardia—Dexamethasone—hematologic cancer	0.000176	0.00113	CcSEcCtD
Ketamine—Dermatitis—Nilotinib—hematologic cancer	0.000176	0.00113	CcSEcCtD
Ketamine—Anorexia—Vincristine—hematologic cancer	0.000176	0.00112	CcSEcCtD
Ketamine—Rash—Imatinib—hematologic cancer	0.000176	0.00112	CcSEcCtD
Ketamine—Dermatitis—Imatinib—hematologic cancer	0.000175	0.00112	CcSEcCtD
Ketamine—Anaphylactic shock—Gemcitabine—hematologic cancer	0.000175	0.00112	CcSEcCtD
Ketamine—Decreased appetite—Thalidomide—hematologic cancer	0.000175	0.00112	CcSEcCtD
Ketamine—Vomiting—Cladribine—hematologic cancer	0.000174	0.00111	CcSEcCtD
Ketamine—Convulsion—Cisplatin—hematologic cancer	0.000173	0.00111	CcSEcCtD
Ketamine—Hypotension—Vincristine—hematologic cancer	0.000173	0.0011	CcSEcCtD
Ketamine—Rash—Cladribine—hematologic cancer	0.000173	0.0011	CcSEcCtD
Ketamine—Dermatitis—Cladribine—hematologic cancer	0.000172	0.0011	CcSEcCtD
Ketamine—Pain—Thalidomide—hematologic cancer	0.000172	0.0011	CcSEcCtD
Ketamine—Anorexia—Mitoxantrone—hematologic cancer	0.000172	0.0011	CcSEcCtD
Ketamine—Anorexia—Irinotecan—hematologic cancer	0.000172	0.0011	CcSEcCtD
Ketamine—Diplopia—Epirubicin—hematologic cancer	0.000171	0.00109	CcSEcCtD
Ketamine—Arrhythmia—Triamcinolone—hematologic cancer	0.000171	0.00109	CcSEcCtD
Ketamine—Vision blurred—Prednisolone—hematologic cancer	0.00017	0.00109	CcSEcCtD
Ketamine—Nausea—Chlorambucil—hematologic cancer	0.00017	0.00109	CcSEcCtD
Ketamine—Decreased appetite—Carmustine—hematologic cancer	0.000168	0.00107	CcSEcCtD
Ketamine—Hypotension—Mitoxantrone—hematologic cancer	0.000168	0.00107	CcSEcCtD
Ketamine—Hypotension—Irinotecan—hematologic cancer	0.000168	0.00107	CcSEcCtD
Ketamine—Anorexia—Gemcitabine—hematologic cancer	0.000167	0.00107	CcSEcCtD
Ketamine—Vomiting—Vinblastine—hematologic cancer	0.000167	0.00107	CcSEcCtD
Ketamine—Decreased appetite—Alitretinoin—hematologic cancer	0.000167	0.00106	CcSEcCtD
Ketamine—Nausea—Nilotinib—hematologic cancer	0.000166	0.00106	CcSEcCtD
Ketamine—Erythema—Triamcinolone—hematologic cancer	0.000166	0.00106	CcSEcCtD
Ketamine—Pain—Carmustine—hematologic cancer	0.000166	0.00106	CcSEcCtD
Ketamine—Nausea—Imatinib—hematologic cancer	0.000165	0.00106	CcSEcCtD
Ketamine—Decreased appetite—Ifosfamide—hematologic cancer	0.000165	0.00105	CcSEcCtD
Ketamine—Pain—Alitretinoin—hematologic cancer	0.000164	0.00105	CcSEcCtD
Ketamine—Hypotension—Gemcitabine—hematologic cancer	0.000164	0.00105	CcSEcCtD
Ketamine—Anaphylactic shock—Cisplatin—hematologic cancer	0.000163	0.00104	CcSEcCtD
Ketamine—Nausea—Cladribine—hematologic cancer	0.000163	0.00104	CcSEcCtD
Ketamine—Pain—Ifosfamide—hematologic cancer	0.000162	0.00103	CcSEcCtD
Ketamine—Decreased appetite—Vincristine—hematologic cancer	0.000161	0.00103	CcSEcCtD
Ketamine—Convulsion—Etoposide—hematologic cancer	0.000159	0.00101	CcSEcCtD
Ketamine—Vomiting—Melphalan—hematologic cancer	0.000159	0.00101	CcSEcCtD
Ketamine—Pain—Vincristine—hematologic cancer	0.000158	0.00101	CcSEcCtD
Ketamine—Diplopia—Doxorubicin—hematologic cancer	0.000158	0.00101	CcSEcCtD
Ketamine—Rash—Melphalan—hematologic cancer	0.000157	0.00101	CcSEcCtD
Ketamine—Dermatitis—Melphalan—hematologic cancer	0.000157	0.001	CcSEcCtD
Ketamine—Convulsion—Prednisolone—hematologic cancer	0.000157	0.001	CcSEcCtD
Ketamine—Decreased appetite—Mitoxantrone—hematologic cancer	0.000156	0.000999	CcSEcCtD
Ketamine—Decreased appetite—Irinotecan—hematologic cancer	0.000156	0.000999	CcSEcCtD
Ketamine—Nausea—Vinblastine—hematologic cancer	0.000156	0.000996	CcSEcCtD
Ketamine—Anorexia—Cisplatin—hematologic cancer	0.000156	0.000994	CcSEcCtD
Ketamine—Arrhythmia—Dexamethasone—hematologic cancer	0.000155	0.000989	CcSEcCtD
Ketamine—Arrhythmia—Betamethasone—hematologic cancer	0.000155	0.000989	CcSEcCtD
Ketamine—Vomiting—Lenalidomide—hematologic cancer	0.000154	0.000986	CcSEcCtD
Ketamine—Pain—Irinotecan—hematologic cancer	0.000154	0.000982	CcSEcCtD
Ketamine—Pain—Mitoxantrone—hematologic cancer	0.000154	0.000982	CcSEcCtD
Ketamine—Bradycardia—Prednisone—hematologic cancer	0.000154	0.000981	CcSEcCtD
Ketamine—ABCB1—lymph node—hematologic cancer	0.000153	0.00406	CbGeAlD
Ketamine—Rash—Lenalidomide—hematologic cancer	0.000153	0.000977	CcSEcCtD
Ketamine—Dermatitis—Lenalidomide—hematologic cancer	0.000153	0.000977	CcSEcCtD
Ketamine—Hypotension—Cisplatin—hematologic cancer	0.000153	0.000975	CcSEcCtD
Ketamine—Decreased appetite—Gemcitabine—hematologic cancer	0.000152	0.000973	CcSEcCtD
Ketamine—Vomiting—Hydroxyurea—hematologic cancer	0.000152	0.000972	CcSEcCtD
Ketamine—Rash—Hydroxyurea—hematologic cancer	0.000151	0.000964	CcSEcCtD
Ketamine—Erythema—Dexamethasone—hematologic cancer	0.000151	0.000964	CcSEcCtD
Ketamine—Erythema—Betamethasone—hematologic cancer	0.000151	0.000964	CcSEcCtD
Ketamine—Dermatitis—Hydroxyurea—hematologic cancer	0.000151	0.000963	CcSEcCtD
Ketamine—Pain—Gemcitabine—hematologic cancer	0.00015	0.000957	CcSEcCtD
Ketamine—Anaphylactic shock—Etoposide—hematologic cancer	0.00015	0.000956	CcSEcCtD
Ketamine—Nausea—Melphalan—hematologic cancer	0.000148	0.000947	CcSEcCtD
Ketamine—Anaphylactic shock—Prednisolone—hematologic cancer	0.000148	0.000942	CcSEcCtD
Ketamine—Shock—Prednisolone—hematologic cancer	0.000145	0.000927	CcSEcCtD
Ketamine—Nausea—Lenalidomide—hematologic cancer	0.000144	0.000921	CcSEcCtD
Ketamine—Convulsion—Triamcinolone—hematologic cancer	0.000144	0.00092	CcSEcCtD
Ketamine—Anorexia—Etoposide—hematologic cancer	0.000143	0.000911	CcSEcCtD
Ketamine—Nausea—Hydroxyurea—hematologic cancer	0.000142	0.000908	CcSEcCtD
Ketamine—Vomiting—Bortezomib—hematologic cancer	0.000142	0.000907	CcSEcCtD
Ketamine—Decreased appetite—Cisplatin—hematologic cancer	0.000142	0.000907	CcSEcCtD
Ketamine—Vomiting—Bleomycin—hematologic cancer	0.000141	0.0009	CcSEcCtD
Ketamine—Rash—Bortezomib—hematologic cancer	0.000141	0.000899	CcSEcCtD
Ketamine—Dermatitis—Bortezomib—hematologic cancer	0.000141	0.000899	CcSEcCtD
Ketamine—Hypotension—Etoposide—hematologic cancer	0.00014	0.000893	CcSEcCtD
Ketamine—Rash—Bleomycin—hematologic cancer	0.00014	0.000893	CcSEcCtD
Ketamine—Pain—Cisplatin—hematologic cancer	0.00014	0.000892	CcSEcCtD
Ketamine—Dermatitis—Bleomycin—hematologic cancer	0.00014	0.000892	CcSEcCtD
Ketamine—Vomiting—Vinorelbine—hematologic cancer	0.000139	0.000886	CcSEcCtD
Ketamine—Rash—Vinorelbine—hematologic cancer	0.000138	0.000878	CcSEcCtD
Ketamine—Dermatitis—Vinorelbine—hematologic cancer	0.000137	0.000877	CcSEcCtD
Ketamine—Anaphylactic shock—Triamcinolone—hematologic cancer	0.000136	0.000867	CcSEcCtD
Ketamine—Arrhythmia—Prednisone—hematologic cancer	0.000135	0.000861	CcSEcCtD
Ketamine—Shock—Triamcinolone—hematologic cancer	0.000134	0.000853	CcSEcCtD
Ketamine—Nausea—Bortezomib—hematologic cancer	0.000133	0.000847	CcSEcCtD
Ketamine—Vomiting—Thiotepa—hematologic cancer	0.000132	0.000846	CcSEcCtD
Ketamine—Nausea—Bleomycin—hematologic cancer	0.000132	0.000841	CcSEcCtD
Ketamine—Erythema—Prednisone—hematologic cancer	0.000131	0.000839	CcSEcCtD
Ketamine—Rash—Thiotepa—hematologic cancer	0.000131	0.000839	CcSEcCtD
Ketamine—Dermatitis—Thiotepa—hematologic cancer	0.000131	0.000838	CcSEcCtD
Ketamine—Convulsion—Dexamethasone—hematologic cancer	0.000131	0.000835	CcSEcCtD
Ketamine—Convulsion—Betamethasone—hematologic cancer	0.000131	0.000835	CcSEcCtD
Ketamine—Decreased appetite—Etoposide—hematologic cancer	0.00013	0.000831	CcSEcCtD
Ketamine—Nausea—Vinorelbine—hematologic cancer	0.00013	0.000827	CcSEcCtD
Ketamine—Vomiting—Thalidomide—hematologic cancer	0.000128	0.000818	CcSEcCtD
Ketamine—Pain—Etoposide—hematologic cancer	0.000128	0.000817	CcSEcCtD
Ketamine—Rash—Thalidomide—hematologic cancer	0.000127	0.000811	CcSEcCtD
Ketamine—Dermatitis—Thalidomide—hematologic cancer	0.000127	0.000811	CcSEcCtD
Ketamine—Pain—Prednisolone—hematologic cancer	0.000126	0.000806	CcSEcCtD
Ketamine—Vision blurred—Prednisone—hematologic cancer	0.000124	0.000791	CcSEcCtD
Ketamine—Nausea—Thiotepa—hematologic cancer	0.000124	0.00079	CcSEcCtD
Ketamine—Anaphylactic shock—Dexamethasone—hematologic cancer	0.000123	0.000786	CcSEcCtD
Ketamine—Anaphylactic shock—Betamethasone—hematologic cancer	0.000123	0.000786	CcSEcCtD
Ketamine—Vomiting—Carmustine—hematologic cancer	0.000123	0.000786	CcSEcCtD
Ketamine—Rash—Carmustine—hematologic cancer	0.000122	0.000779	CcSEcCtD
Ketamine—Dermatitis—Carmustine—hematologic cancer	0.000122	0.000778	CcSEcCtD
Ketamine—Vomiting—Alitretinoin—hematologic cancer	0.000122	0.000778	CcSEcCtD
Ketamine—Shock—Dexamethasone—hematologic cancer	0.000121	0.000774	CcSEcCtD
Ketamine—Shock—Betamethasone—hematologic cancer	0.000121	0.000774	CcSEcCtD
Ketamine—Rash—Alitretinoin—hematologic cancer	0.000121	0.000772	CcSEcCtD
Ketamine—Dermatitis—Alitretinoin—hematologic cancer	0.000121	0.000771	CcSEcCtD
Ketamine—Vomiting—Ifosfamide—hematologic cancer	0.00012	0.000769	CcSEcCtD
Ketamine—Bradycardia—Epirubicin—hematologic cancer	0.00012	0.000768	CcSEcCtD
Ketamine—Nausea—Thalidomide—hematologic cancer	0.00012	0.000764	CcSEcCtD
Ketamine—Rash—Ifosfamide—hematologic cancer	0.000119	0.000763	CcSEcCtD
Ketamine—Dermatitis—Ifosfamide—hematologic cancer	0.000119	0.000762	CcSEcCtD
Ketamine—Vomiting—Vincristine—hematologic cancer	0.000117	0.00075	CcSEcCtD
Ketamine—Anorexia—Betamethasone—hematologic cancer	0.000117	0.00075	CcSEcCtD
Ketamine—Anorexia—Dexamethasone—hematologic cancer	0.000117	0.00075	CcSEcCtD
Ketamine—Rash—Vincristine—hematologic cancer	0.000116	0.000744	CcSEcCtD
Ketamine—Dermatitis—Vincristine—hematologic cancer	0.000116	0.000743	CcSEcCtD
Ketamine—Pain—Triamcinolone—hematologic cancer	0.000116	0.000741	CcSEcCtD
Ketamine—Hypotension—Betamethasone—hematologic cancer	0.000115	0.000735	CcSEcCtD
Ketamine—Hypotension—Dexamethasone—hematologic cancer	0.000115	0.000735	CcSEcCtD
Ketamine—Nausea—Carmustine—hematologic cancer	0.000115	0.000734	CcSEcCtD
Ketamine—Vomiting—Irinotecan—hematologic cancer	0.000114	0.00073	CcSEcCtD
Ketamine—Vomiting—Mitoxantrone—hematologic cancer	0.000114	0.00073	CcSEcCtD
Ketamine—Nausea—Alitretinoin—hematologic cancer	0.000114	0.000727	CcSEcCtD
Ketamine—Convulsion—Prednisone—hematologic cancer	0.000114	0.000727	CcSEcCtD
Ketamine—Rash—Irinotecan—hematologic cancer	0.000113	0.000724	CcSEcCtD
Ketamine—Rash—Mitoxantrone—hematologic cancer	0.000113	0.000724	CcSEcCtD
Ketamine—Dermatitis—Mitoxantrone—hematologic cancer	0.000113	0.000724	CcSEcCtD
Ketamine—Dermatitis—Irinotecan—hematologic cancer	0.000113	0.000724	CcSEcCtD
Ketamine—Nausea—Ifosfamide—hematologic cancer	0.000113	0.000719	CcSEcCtD
Ketamine—Vomiting—Gemcitabine—hematologic cancer	0.000111	0.000712	CcSEcCtD
Ketamine—Bradycardia—Doxorubicin—hematologic cancer	0.000111	0.00071	CcSEcCtD
Ketamine—Rash—Gemcitabine—hematologic cancer	0.000111	0.000706	CcSEcCtD
Ketamine—Dermatitis—Gemcitabine—hematologic cancer	0.00011	0.000705	CcSEcCtD
Ketamine—Erythema—Methotrexate—hematologic cancer	0.00011	0.000701	CcSEcCtD
Ketamine—Nausea—Vincristine—hematologic cancer	0.00011	0.000701	CcSEcCtD
Ketamine—Anaphylactic shock—Prednisone—hematologic cancer	0.000107	0.000685	CcSEcCtD
Ketamine—Decreased appetite—Betamethasone—hematologic cancer	0.000107	0.000684	CcSEcCtD
Ketamine—Decreased appetite—Dexamethasone—hematologic cancer	0.000107	0.000684	CcSEcCtD
Ketamine—Nausea—Mitoxantrone—hematologic cancer	0.000107	0.000682	CcSEcCtD
Ketamine—Nausea—Irinotecan—hematologic cancer	0.000107	0.000682	CcSEcCtD
Ketamine—Shock—Prednisone—hematologic cancer	0.000106	0.000674	CcSEcCtD
Ketamine—Arrhythmia—Epirubicin—hematologic cancer	0.000105	0.000674	CcSEcCtD
Ketamine—Pain—Dexamethasone—hematologic cancer	0.000105	0.000673	CcSEcCtD
Ketamine—Pain—Betamethasone—hematologic cancer	0.000105	0.000673	CcSEcCtD
Ketamine—Nausea—Gemcitabine—hematologic cancer	0.000104	0.000665	CcSEcCtD
Ketamine—Vomiting—Cisplatin—hematologic cancer	0.000104	0.000663	CcSEcCtD
Ketamine—Vision blurred—Methotrexate—hematologic cancer	0.000104	0.000661	CcSEcCtD
Ketamine—Rash—Cisplatin—hematologic cancer	0.000103	0.000658	CcSEcCtD
Ketamine—Dermatitis—Cisplatin—hematologic cancer	0.000103	0.000657	CcSEcCtD
Ketamine—Erythema—Epirubicin—hematologic cancer	0.000103	0.000656	CcSEcCtD
Ketamine—Anorexia—Prednisone—hematologic cancer	0.000102	0.000653	CcSEcCtD
Ketamine—Arrhythmia—Doxorubicin—hematologic cancer	9.76e-05	0.000623	CcSEcCtD
Ketamine—Nausea—Cisplatin—hematologic cancer	9.7e-05	0.00062	CcSEcCtD
Ketamine—Vision blurred—Epirubicin—hematologic cancer	9.69e-05	0.000619	CcSEcCtD
Ketamine—Convulsion—Methotrexate—hematologic cancer	9.52e-05	0.000608	CcSEcCtD
Ketamine—Vomiting—Etoposide—hematologic cancer	9.52e-05	0.000608	CcSEcCtD
Ketamine—Erythema—Doxorubicin—hematologic cancer	9.51e-05	0.000607	CcSEcCtD
Ketamine—Rash—Etoposide—hematologic cancer	9.44e-05	0.000603	CcSEcCtD
Ketamine—Dermatitis—Etoposide—hematologic cancer	9.43e-05	0.000602	CcSEcCtD
Ketamine—Decreased appetite—Prednisone—hematologic cancer	9.32e-05	0.000595	CcSEcCtD
Ketamine—Rash—Prednisolone—hematologic cancer	9.31e-05	0.000594	CcSEcCtD
Ketamine—Dermatitis—Prednisolone—hematologic cancer	9.3e-05	0.000594	CcSEcCtD
Ketamine—Anaphylactic shock—Methotrexate—hematologic cancer	8.96e-05	0.000572	CcSEcCtD
Ketamine—Vision blurred—Doxorubicin—hematologic cancer	8.96e-05	0.000572	CcSEcCtD
Ketamine—Convulsion—Epirubicin—hematologic cancer	8.91e-05	0.000569	CcSEcCtD
Ketamine—Nausea—Etoposide—hematologic cancer	8.89e-05	0.000568	CcSEcCtD
Ketamine—Nausea—Prednisolone—hematologic cancer	8.77e-05	0.00056	CcSEcCtD
Ketamine—Vomiting—Triamcinolone—hematologic cancer	8.63e-05	0.000551	CcSEcCtD
Ketamine—Rash—Triamcinolone—hematologic cancer	8.56e-05	0.000546	CcSEcCtD
Ketamine—Dermatitis—Triamcinolone—hematologic cancer	8.55e-05	0.000546	CcSEcCtD
Ketamine—Anorexia—Methotrexate—hematologic cancer	8.55e-05	0.000546	CcSEcCtD
Ketamine—Anaphylactic shock—Epirubicin—hematologic cancer	8.39e-05	0.000536	CcSEcCtD
Ketamine—Hypotension—Methotrexate—hematologic cancer	8.38e-05	0.000535	CcSEcCtD
Ketamine—Shock—Epirubicin—hematologic cancer	8.25e-05	0.000527	CcSEcCtD
Ketamine—Convulsion—Doxorubicin—hematologic cancer	8.24e-05	0.000526	CcSEcCtD
Ketamine—Nausea—Triamcinolone—hematologic cancer	8.06e-05	0.000515	CcSEcCtD
Ketamine—Anorexia—Epirubicin—hematologic cancer	8e-05	0.000511	CcSEcCtD
Ketamine—Hypotension—Epirubicin—hematologic cancer	7.84e-05	0.000501	CcSEcCtD
Ketamine—Vomiting—Dexamethasone—hematologic cancer	7.83e-05	0.0005	CcSEcCtD
Ketamine—Vomiting—Betamethasone—hematologic cancer	7.83e-05	0.0005	CcSEcCtD
Ketamine—Decreased appetite—Methotrexate—hematologic cancer	7.79e-05	0.000498	CcSEcCtD
Ketamine—Rash—Betamethasone—hematologic cancer	7.77e-05	0.000496	CcSEcCtD
Ketamine—Rash—Dexamethasone—hematologic cancer	7.77e-05	0.000496	CcSEcCtD
Ketamine—Anaphylactic shock—Doxorubicin—hematologic cancer	7.76e-05	0.000496	CcSEcCtD
Ketamine—Dermatitis—Betamethasone—hematologic cancer	7.76e-05	0.000495	CcSEcCtD
Ketamine—Dermatitis—Dexamethasone—hematologic cancer	7.76e-05	0.000495	CcSEcCtD
Ketamine—Pain—Methotrexate—hematologic cancer	7.67e-05	0.000489	CcSEcCtD
Ketamine—Shock—Doxorubicin—hematologic cancer	7.64e-05	0.000488	CcSEcCtD
Ketamine—Anorexia—Doxorubicin—hematologic cancer	7.4e-05	0.000472	CcSEcCtD
Ketamine—Nausea—Betamethasone—hematologic cancer	7.32e-05	0.000467	CcSEcCtD
Ketamine—Nausea—Dexamethasone—hematologic cancer	7.32e-05	0.000467	CcSEcCtD
Ketamine—Decreased appetite—Epirubicin—hematologic cancer	7.29e-05	0.000466	CcSEcCtD
Ketamine—Hypotension—Doxorubicin—hematologic cancer	7.25e-05	0.000463	CcSEcCtD
Ketamine—Pain—Epirubicin—hematologic cancer	7.17e-05	0.000458	CcSEcCtD
Ketamine—Vomiting—Prednisone—hematologic cancer	6.82e-05	0.000435	CcSEcCtD
Ketamine—Rash—Prednisone—hematologic cancer	6.76e-05	0.000432	CcSEcCtD
Ketamine—Dermatitis—Prednisone—hematologic cancer	6.76e-05	0.000431	CcSEcCtD
Ketamine—Decreased appetite—Doxorubicin—hematologic cancer	6.75e-05	0.000431	CcSEcCtD
Ketamine—Pain—Doxorubicin—hematologic cancer	6.64e-05	0.000424	CcSEcCtD
Ketamine—Nausea—Prednisone—hematologic cancer	6.37e-05	0.000407	CcSEcCtD
Ketamine—Vomiting—Methotrexate—hematologic cancer	5.7e-05	0.000364	CcSEcCtD
Ketamine—Rash—Methotrexate—hematologic cancer	5.65e-05	0.000361	CcSEcCtD
Ketamine—Dermatitis—Methotrexate—hematologic cancer	5.65e-05	0.000361	CcSEcCtD
Ketamine—Vomiting—Epirubicin—hematologic cancer	5.33e-05	0.000341	CcSEcCtD
Ketamine—Nausea—Methotrexate—hematologic cancer	5.32e-05	0.00034	CcSEcCtD
Ketamine—Rash—Epirubicin—hematologic cancer	5.29e-05	0.000338	CcSEcCtD
Ketamine—Dermatitis—Epirubicin—hematologic cancer	5.28e-05	0.000337	CcSEcCtD
Ketamine—Nausea—Epirubicin—hematologic cancer	4.98e-05	0.000318	CcSEcCtD
Ketamine—Vomiting—Doxorubicin—hematologic cancer	4.94e-05	0.000315	CcSEcCtD
Ketamine—Rash—Doxorubicin—hematologic cancer	4.89e-05	0.000312	CcSEcCtD
Ketamine—Dermatitis—Doxorubicin—hematologic cancer	4.89e-05	0.000312	CcSEcCtD
Ketamine—Nausea—Doxorubicin—hematologic cancer	4.61e-05	0.000294	CcSEcCtD
Ketamine—OPRD1—Signaling Pathways—JUN—hematologic cancer	3.48e-06	2.47e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.47e-06	2.47e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—NQO1—hematologic cancer	3.47e-06	2.47e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CD44—hematologic cancer	3.47e-06	2.47e-05	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—AKT1—hematologic cancer	3.44e-06	2.45e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.44e-06	2.44e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IL2RA—hematologic cancer	3.43e-06	2.44e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PIK3CB—hematologic cancer	3.41e-06	2.43e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MTOR—hematologic cancer	3.41e-06	2.43e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—MTHFR—hematologic cancer	3.41e-06	2.42e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—IL2—hematologic cancer	3.4e-06	2.42e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.4e-06	2.41e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TERT—hematologic cancer	3.39e-06	2.41e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CDKN1A—hematologic cancer	3.37e-06	2.4e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—PTEN—hematologic cancer	3.37e-06	2.39e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—ABCB1—hematologic cancer	3.36e-06	2.39e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.34e-06	2.37e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MAP2K1—hematologic cancer	3.33e-06	2.37e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PIK3CD—hematologic cancer	3.31e-06	2.35e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PDGFB—hematologic cancer	3.31e-06	2.35e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PIK3CD—hematologic cancer	3.3e-06	2.35e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MAPK8—hematologic cancer	3.29e-06	2.34e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—AKT1—hematologic cancer	3.28e-06	2.33e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CYCS—hematologic cancer	3.28e-06	2.33e-05	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—PIK3CA—hematologic cancer	3.28e-06	2.33e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—GSTM1—hematologic cancer	3.27e-06	2.32e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—NCOR1—hematologic cancer	3.27e-06	2.32e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	3.26e-06	2.32e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—HRAS—hematologic cancer	3.26e-06	2.32e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—ALB—hematologic cancer	3.26e-06	2.32e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.25e-06	2.31e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.25e-06	2.31e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—KRAS—hematologic cancer	3.24e-06	2.3e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TSC2—hematologic cancer	3.23e-06	2.3e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—EP300—hematologic cancer	3.21e-06	2.28e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CDKN1B—hematologic cancer	3.2e-06	2.28e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—FGF2—hematologic cancer	3.17e-06	2.25e-05	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—AKT1—hematologic cancer	3.17e-06	2.25e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ALOX5—hematologic cancer	3.16e-06	2.25e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CASP3—hematologic cancer	3.14e-06	2.23e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IL2—hematologic cancer	3.14e-06	2.23e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PIK3R1—hematologic cancer	3.13e-06	2.22e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—SRC—hematologic cancer	3.12e-06	2.22e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—IL6—hematologic cancer	3.12e-06	2.22e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PIK3R1—hematologic cancer	3.12e-06	2.22e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—FGFR3—hematologic cancer	3.11e-06	2.21e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—GSTP1—hematologic cancer	3.1e-06	2.2e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MAPK14—hematologic cancer	3.08e-06	2.19e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—NUP98—hematologic cancer	3.06e-06	2.18e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CCND1—hematologic cancer	3.06e-06	2.17e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—JUN—hematologic cancer	3.05e-06	2.17e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—VEGFA—hematologic cancer	3.04e-06	2.16e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—JAK2—hematologic cancer	3.04e-06	2.16e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—ESR1—hematologic cancer	3.02e-06	2.15e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—STAT3—hematologic cancer	3.01e-06	2.14e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—NRAS—hematologic cancer	3e-06	2.13e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—FN1—hematologic cancer	2.98e-06	2.12e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—PIK3CA—hematologic cancer	2.98e-06	2.12e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.97e-06	2.11e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.97e-06	2.11e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MDM2—hematologic cancer	2.97e-06	2.11e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CDKN1A—hematologic cancer	2.96e-06	2.1e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—NUP214—hematologic cancer	2.95e-06	2.1e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PTEN—hematologic cancer	2.95e-06	2.1e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—BAD—hematologic cancer	2.95e-06	2.1e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—NFKBIA—hematologic cancer	2.95e-06	2.1e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.94e-06	2.09e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—NOTCH1—hematologic cancer	2.92e-06	2.07e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—MTR—hematologic cancer	2.89e-06	2.06e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.89e-06	2.06e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GSTP1—hematologic cancer	2.89e-06	2.06e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—MTHFR—hematologic cancer	2.89e-06	2.05e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MAPK8—hematologic cancer	2.89e-06	2.05e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PIK3CB—hematologic cancer	2.89e-06	2.05e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MTOR—hematologic cancer	2.89e-06	2.05e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—AKT1—hematologic cancer	2.88e-06	2.05e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PIK3CB—hematologic cancer	2.88e-06	2.05e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MAPK3—hematologic cancer	2.88e-06	2.04e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PIK3CG—hematologic cancer	2.87e-06	2.04e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CD80—hematologic cancer	2.86e-06	2.03e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—KIT—hematologic cancer	2.85e-06	2.03e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PIK3CG—hematologic cancer	2.85e-06	2.03e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—NRAS—hematologic cancer	2.85e-06	2.03e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—NCOR1—hematologic cancer	2.85e-06	2.02e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—GSTM1—hematologic cancer	2.85e-06	2.02e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ENO2—hematologic cancer	2.84e-06	2.02e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—EP300—hematologic cancer	2.81e-06	2e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PTPN11—hematologic cancer	2.8e-06	1.99e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.8e-06	1.99e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MYC—hematologic cancer	2.8e-06	1.99e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TGFB1—hematologic cancer	2.79e-06	1.98e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—HRAS—hematologic cancer	2.76e-06	1.96e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.75e-06	1.96e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ABCB1—hematologic cancer	2.74e-06	1.95e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—SRC—hematologic cancer	2.74e-06	1.95e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—MAPK3—hematologic cancer	2.73e-06	1.94e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CREB1—hematologic cancer	2.72e-06	1.93e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CDKN1B—hematologic cancer	2.71e-06	1.93e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—SDC1—hematologic cancer	2.69e-06	1.91e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—BRAF—hematologic cancer	2.68e-06	1.91e-05	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—AKT1—hematologic cancer	2.68e-06	1.9e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—VEGFA—hematologic cancer	2.67e-06	1.89e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—NCOR1—hematologic cancer	2.66e-06	1.89e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GSTM1—hematologic cancer	2.66e-06	1.89e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CCL2—hematologic cancer	2.66e-06	1.89e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—CREBBP—hematologic cancer	2.66e-06	1.89e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CASP3—hematologic cancer	2.65e-06	1.89e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IL6R—hematologic cancer	2.65e-06	1.88e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IL2—hematologic cancer	2.65e-06	1.88e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CREBBP—hematologic cancer	2.65e-06	1.88e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—STAT3—hematologic cancer	2.64e-06	1.88e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—IL6—hematologic cancer	2.64e-06	1.87e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—NRAS—hematologic cancer	2.63e-06	1.87e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—KRAS—hematologic cancer	2.58e-06	1.84e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CCND1—hematologic cancer	2.58e-06	1.84e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—JUN—hematologic cancer	2.58e-06	1.83e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.54e-06	1.81e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MAP2K1—hematologic cancer	2.53e-06	1.8e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MAPK3—hematologic cancer	2.52e-06	1.79e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PIK3CD—hematologic cancer	2.52e-06	1.79e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—MTHFR—hematologic cancer	2.52e-06	1.79e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PIK3CD—hematologic cancer	2.51e-06	1.78e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CDKN1A—hematologic cancer	2.5e-06	1.78e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PTEN—hematologic cancer	2.49e-06	1.77e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—ALB—hematologic cancer	2.49e-06	1.77e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PTEN—hematologic cancer	2.49e-06	1.77e-05	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—PIK3CA—hematologic cancer	2.49e-06	1.77e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—KRAS—hematologic cancer	2.46e-06	1.75e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MYC—hematologic cancer	2.45e-06	1.74e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TGFB1—hematologic cancer	2.45e-06	1.74e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MAPK8—hematologic cancer	2.44e-06	1.73e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—AKT1—hematologic cancer	2.43e-06	1.73e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PIK3CG—hematologic cancer	2.43e-06	1.72e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—FGF2—hematologic cancer	2.4e-06	1.71e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—EP300—hematologic cancer	2.38e-06	1.69e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PIK3R1—hematologic cancer	2.38e-06	1.69e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—PIK3CA—hematologic cancer	2.37e-06	1.69e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—EP300—hematologic cancer	2.37e-06	1.69e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PIK3R1—hematologic cancer	2.37e-06	1.68e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—MTHFR—hematologic cancer	2.35e-06	1.67e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—SRC—hematologic cancer	2.31e-06	1.64e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—JAK2—hematologic cancer	2.3e-06	1.64e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TP53—hematologic cancer	2.3e-06	1.63e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—NQO1—hematologic cancer	2.29e-06	1.63e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CD44—hematologic cancer	2.29e-06	1.63e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—KRAS—hematologic cancer	2.27e-06	1.61e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—PIK3CA—hematologic cancer	2.26e-06	1.6e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—VEGFA—hematologic cancer	2.25e-06	1.6e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—CREBBP—hematologic cancer	2.25e-06	1.6e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MDM2—hematologic cancer	2.25e-06	1.6e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—STAT3—hematologic cancer	2.23e-06	1.59e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—NRAS—hematologic cancer	2.22e-06	1.58e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—HRAS—hematologic cancer	2.2e-06	1.56e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PIK3CB—hematologic cancer	2.2e-06	1.56e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MTOR—hematologic cancer	2.19e-06	1.55e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PIK3CB—hematologic cancer	2.19e-06	1.55e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CYCS—hematologic cancer	2.16e-06	1.54e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.15e-06	1.53e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PIK3CD—hematologic cancer	2.13e-06	1.52e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MAPK3—hematologic cancer	2.13e-06	1.51e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PIK3CG—hematologic cancer	2.11e-06	1.5e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—ALB—hematologic cancer	2.1e-06	1.5e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IL6—hematologic cancer	2.1e-06	1.49e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—HRAS—hematologic cancer	2.09e-06	1.48e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PIK3CA—hematologic cancer	2.08e-06	1.48e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MYC—hematologic cancer	2.07e-06	1.47e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.07e-06	1.47e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TGFB1—hematologic cancer	2.07e-06	1.47e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CDKN1B—hematologic cancer	2.05e-06	1.46e-05	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—AKT1—hematologic cancer	2.03e-06	1.44e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TP53—hematologic cancer	2.01e-06	1.43e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PIK3R1—hematologic cancer	2.01e-06	1.43e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CASP3—hematologic cancer	2.01e-06	1.43e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IL2—hematologic cancer	2.01e-06	1.43e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—IL6—hematologic cancer	2e-06	1.42e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PIK3CG—hematologic cancer	1.97e-06	1.4e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CREBBP—hematologic cancer	1.96e-06	1.39e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CCND1—hematologic cancer	1.96e-06	1.39e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—JUN—hematologic cancer	1.95e-06	1.39e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—AKT1—hematologic cancer	1.94e-06	1.38e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—HRAS—hematologic cancer	1.93e-06	1.37e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—KRAS—hematologic cancer	1.92e-06	1.36e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.91e-06	1.36e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PTEN—hematologic cancer	1.9e-06	1.35e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CDKN1A—hematologic cancer	1.89e-06	1.35e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PTEN—hematologic cancer	1.89e-06	1.34e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PIK3CB—hematologic cancer	1.86e-06	1.32e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PIK3CD—hematologic cancer	1.86e-06	1.32e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MAPK8—hematologic cancer	1.85e-06	1.31e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—AKT1—hematologic cancer	1.84e-06	1.31e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IL6—hematologic cancer	1.84e-06	1.31e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—ALB—hematologic cancer	1.83e-06	1.3e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CREBBP—hematologic cancer	1.83e-06	1.3e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—EP300—hematologic cancer	1.81e-06	1.29e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.81e-06	1.28e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—EP300—hematologic cancer	1.8e-06	1.28e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PIK3CA—hematologic cancer	1.76e-06	1.25e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.75e-06	1.25e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PIK3CA—hematologic cancer	1.75e-06	1.25e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.75e-06	1.25e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.75e-06	1.25e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—SRC—hematologic cancer	1.75e-06	1.25e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.74e-06	1.23e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ALB—hematologic cancer	1.71e-06	1.22e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—VEGFA—hematologic cancer	1.71e-06	1.21e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TP53—hematologic cancer	1.7e-06	1.21e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—AKT1—hematologic cancer	1.7e-06	1.21e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—STAT3—hematologic cancer	1.69e-06	1.2e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—NRAS—hematologic cancer	1.69e-06	1.2e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.64e-06	1.16e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—HRAS—hematologic cancer	1.63e-06	1.16e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.62e-06	1.15e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MAPK3—hematologic cancer	1.61e-06	1.15e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PTEN—hematologic cancer	1.61e-06	1.14e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MYC—hematologic cancer	1.57e-06	1.12e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TGFB1—hematologic cancer	1.57e-06	1.11e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IL6—hematologic cancer	1.56e-06	1.11e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.55e-06	1.1e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—EP300—hematologic cancer	1.53e-06	1.09e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.51e-06	1.08e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—KRAS—hematologic cancer	1.45e-06	1.03e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—AKT1—hematologic cancer	1.44e-06	1.02e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—AKT1—hematologic cancer	1.43e-06	1.02e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PTEN—hematologic cancer	1.4e-06	9.95e-06	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PIK3CA—hematologic cancer	1.34e-06	9.51e-06	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—EP300—hematologic cancer	1.33e-06	9.48e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PIK3CA—hematologic cancer	1.33e-06	9.48e-06	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PTEN—hematologic cancer	1.31e-06	9.29e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.3e-06	9.25e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TP53—hematologic cancer	1.29e-06	9.17e-06	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—EP300—hematologic cancer	1.25e-06	8.86e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—HRAS—hematologic cancer	1.23e-06	8.77e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.21e-06	8.58e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IL6—hematologic cancer	1.18e-06	8.39e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.14e-06	8.14e-06	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.13e-06	8.05e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ALB—hematologic cancer	1.13e-06	8.03e-06	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—AKT1—hematologic cancer	1.09e-06	7.77e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—AKT1—hematologic cancer	1.09e-06	7.74e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.08e-06	7.68e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	9.98e-07	7.09e-06	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PIK3CA—hematologic cancer	9.87e-07	7.02e-06	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—AKT1—hematologic cancer	9.26e-07	6.58e-06	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PIK3CA—hematologic cancer	9.22e-07	6.55e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PTEN—hematologic cancer	8.62e-07	6.13e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—EP300—hematologic cancer	8.22e-07	5.84e-06	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—AKT1—hematologic cancer	8.06e-07	5.73e-06	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—AKT1—hematologic cancer	7.53e-07	5.35e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	6.08e-07	4.32e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—AKT1—hematologic cancer	4.97e-07	3.53e-06	CbGpPWpGaD
